Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the Leerink Partners 2015 Global Healthcare Conference being held February 11-12, 2015 at the Waldorf Astoria in New York City. The Company is scheduled to present on Wednesday, February 11 at 11:05am (ET) and will provide a corporate update on the KALBITOR® (ecallantide) business, DX-2930 and the Licensing and Funded Research Portfolio (LFRP).
Help employers find you! Check out all the jobs and post your resume.
